SYDNEY, July 9, 2025 -- Kazia Therapeutics (NASDAQ: KZIA) is pleased to announce preliminary results from the first patient in its Phase 1b trial evaluating a combination regimen of Paxalisib, pembrolizumab (Keytruda®), and standard chemotherapy after completing Cycle 1 (21 days) of dosing. The patient, a 61-year-old woman with metastatic triple-negative breast cancer localized to the left upper lobe of the lung, has shown highly encouraging preliminary results at 21 days, with a >50% reduction in circulating tumor cells (CTCs) and a notable decrease in CTC clusters. The early d
南京、上海和美国旧金山 2025年7月9日 -- 驯鹿生物,一家致力于细胞和抗体创新药物研发、生产和销售的生物制药公司,宣布韩国食品药品安全部(Ministry of Food and Drug Safety, MFDS)授予其自主研发的靶向BCMA的CAR-T细胞治疗产品伊基奥仑赛注射液(Fucaso)孤儿药资格认定(Orphan Drug Designation, ODD),用于治疗既往经过至少三线治疗后出现疾病进展(至少使用过一种蛋白酶体抑制剂及免疫调节剂)的复发或难治性多发性骨髓瘤(R/R MM)成人患者。 目前,韩国MFDS对孤儿药的认定标准为:1)发病人数少于20,000人;2)药物用于治疗尚未开发出适当疗法的疾病,或与现有替代疗法相比安全性/有效性明显提高。对于"境外有药,境内无药"的孤儿药,韩国鼓励孤儿药进口*。伊基奥仑赛注射液获得ODD后有望加速在韩国的注册审批,使当地患者早日获益。 驯鹿生物创始人、董事长兼首席执行官张金华女士表示:"此次伊基奥仑赛注射液在韩国获得孤儿药资格认定,是继今年5月获得沙特阿拉伯ODD后,该产品取得的又一重要国际监管认可。这一认定有望加快这款CAR-T药品在韩国的可及性。驯鹿生物正以‘多国并行、区域协同'的国际注册战略,推动该创新细
杭州 2025年7月9日 -- 为深入践行2025年"7.8全国保险公众宣传日"的"爱和责任 保险让生活更美好"主题精神,平安养老保险股份有限公司(以下简称"平安养老险")浙江分公司结合红色传承和公益实践,于7月3日组织总经理室成员及员工代表赴浙江省廉洁文化教育基地胡公馆,开展了一场意义深远的健步行主题活动。通过廉洁学习、公益毅行与开展防范金融风险宣传,深刻诠释保险人的职责与担当。 胡公馆内,全体人员接受了一场深刻的责任教育洗礼。胡公"为官一任,造福一方"的为民情怀与担当精神,穿越历史烟云,与"保险让生活更美好"的当代使命遥相呼应。大家在展陈前驻足沉思,感悟先贤以民为本的初心,正是"责任"二字最厚重的历史注脚。清风廉韵,涤荡心灵,这份沉甸甸的为民守护之责,也是保险人的出发点和落脚点。 责任行路,爱在青山:公益足迹践行守护承诺 带着这份感悟,平安养老险浙江分公司全体成员在健步途中,将目光所及的纸屑、杂物和塑料瓶等散落物一一拾起,以行动诠释"爱"的广度与"责任"的深度,每一次弯腰,都是对绿水青山的深情守护,也是保险人"守护美好生活"的实际表达。 筑牢防
HONG KONG, July 9, 2025 -- SU Group Holdings Limited (Nasdaq: SUGP) ("SU Group" or the "Company"), an integrated security-related engineering services company in Hong Kong, today announced it has been awarded the largest contract in the Company's history, valued at HK$88.5 million (approximately US$11.3 million). The landmark contract involves the design, delivery, and integration of a full spectrum of security, monitoring, public address, and safety systems for a major hospital expansion and upgrade project in Hong Kong. The Company will imple
[ 메디채널 기자 ] 애시버로, 노스캐롤라이나주, 2025년 7월 9일 -- 의료•소비재 포장•산업 제조 분야의 세계적인 선도기업인 테크니마크(Technimark)가 8일 새로운 브랜드 아이덴티티를 공개했다. 이번 리브랜딩은 신뢰성과 우수성으로 인정받는 글로벌 제조 분야 리더로 회사의 변화를 반영해 추진됐다. 이 새로운 브랜드 아이덴티티에는 테크니마크의 핵심 가치인 혁신, 품질, 서비스, 지속 가능성, 신뢰가 담겨있다. 또한 의료 분야에서 확대된 회사의 존재감, 소비자 포장 분야에서 유지하고 있는 리더십, 운영의 우수성과 고객 성공을 위한 흔들리지 않는 노력도 강조한다. 크리스 피비(Kris Peavy) 테크니마크 의료 부문 최고상업책임자(COO) 겸 사장은 "우리는 단순히 브랜드의 외형만 새롭게 바꾼 게 아니다"라며 "오늘의 우리와 내일의 방향을 보여주는 선언을 한 것"이라고 말했다. 그는 이어 "우리의 새로운 브랜드 아이덴티티는 진정한 솔루션 파트너로서 우리가 얼마나 가치가 있는 존재인지를 보여준다"면서 "우리는 고객과 함께 도전을 극복하고, 혁신적
[ 메디채널 기자 ] Fund Anchored by Townsend Group, Leading Pension Fund and Asia Family Offices HONG KONG, July 9, 2025 -- Avatar Capital Partners ("ACP"), an Asia-based asset management platform, today announced the final close of its inaugural real estate fund, ACP Real Estate Fund I (the "Fund") at JPY 15.2 billion (USD105 million). This Tokyo living sector focused fund has attracted significant interest, achieving an oversubscribed final close within just one year of its launch. Townsend Group ("Townsend"), a leading advisor and partner to instit
[ 메디채널 기자 ] 携手涛涛车业和福然德开启人形机器人全球化商业新征程 上海 2025年7月9日 -- 近期,在人形机器人产业蓬勃发展的浪潮中,开普勒机器人迎来了一个意义非凡的时刻 —— 成功完成 A + 轮战略融资。浙江涛涛车业股份有限公司和福然德股份有限公司的加入,注入了强劲动力,也标志着开普勒迈向全球化商业布局的新征程正式开启。 回首过往,开普勒以坚定的步伐和创新的精神,在融资道路上一路前行,近半年来已顺利完成 3轮融资。此次 A + 轮融资的新伙伴,同样实力超群。 福然德股份有限公司成立于2004 年,上海证券交易所主板上市企业,证券代码:605050;福然德深耕汽车行业多年,获得了汽车行业相关上、下游企业的高度认可,是中高端汽车主机厂及其配套商的长期、稳定、胜任的合作伙伴。作为深耕汽车行业多年的上市企业,在中高端汽车主机厂及其配套商领域拥有深厚的合作基础,也有汽车材料轻化在人形机器人上应用的产能优势。福然德对人形机器人在汽车行业的应用发展前景充满信心。未来,福然德和开普勒将通过渠道共建的合作模式,强强联合,加速推进和强化人形机器人的制造以及应用落地布局发展。福然德的加入,将助力开普勒在垂直行业的市场拓展及商业化的竞争力。 众所周知,硬件始终是人形机器人产业发展的根基。即便
WUHAN, China, July 9, 2025 -- China Automotive Systems, Inc. (Nasdaq: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier in China, today announced that its L2+ standard electro-hydraulic steering system, a power steering system used in heavy-duty vehicles that utilizes both hydraulic power and electronic controls to assist with steering, has entered mass production in China. Following the iRCB 's outstanding performance and cost-efficiency demonstrated in the first month of mass production, new orders in July were placed by customers
XIAMEN, China, July 9, 2025 -- Xtep, a leading Chinese performance sportswear brand, announces that applications for its inaugural global Elite Runner Program will close on July 14. The first edition of the program kicks off at Shenyang Marathon in China on September 14, offering elite runners worldwide exclusive access to premier marathons. The program provides world-class athletes with a unique opportunity to pursue personal bests (PBs) at premier marathons. Beyond this, Xtep supports elite runners by sponsoring professional-grade Xtep race apparel & footwear, and coverin
KUALA LUMPUR, Malaysia, July 9, 2025 -- In a significant move to advance corporate wellness and social responsibility, SBS Digital Holdings Sdn Bhd (SBS Group) has signed a strategic partnership with the National Cancer Society of Malaysia (NCSM). This landmark collaboration aims to mobilize at least 100 companies within the next 12 months to foster healthier, more compassionate workplaces across Malaysia. The Memorandum of Understanding (MoU) was officially inked by Mr. CM Wong, Founder of SBS Group, and Dr. Murallitharan, Chief Executive Officer of NCSM. The partnership marks